| Literature DB >> 17350254 |
Jianke Li1, Brian D Wakefield, J Craig Ruble, Cory M Stiff, Donna L Romero, Keith R Marotti, Michael T Sweeney, Gary E Zurenko, Douglas C Rohrer, Atli Thorarensen.
Abstract
Discovery of novel antibacterial agents is a significant challenge. We have recently reported on our discovery of novel antibacterial agents in which we have rapidly optimized potency utilizing a parallel chemistry approach. These advanced leads suffer from high affinity for human serum albumin (HSA). In an effort to decrease the affinity for HSA we have prepared a series of heterocyclic analogs, which retained antibacterial activity and demonstrated reduced affinity for HSA.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17350254 DOI: 10.1016/j.bmcl.2006.12.055
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823